PDP - (Invesco DWA Momentum ETF)

 PDPのチャート


 PDPの企業情報

symbol PDP
会社名
分野(sector)   
産業(industry)   
業種 投資信託  
概要 事業概要 パワーシェアーズ・ディーダブリューエー・テクニカル・リーダーズ・ポートフォリオ(PowerShares DWA Technical Leaders Portfolio)はDorsey Wright Technical Leaders Index(同指数)に基づく。同ファンドは同指数の価格および利回りの実績に概ね対応する投資成果( 手数料および経費控除前)をあげることを投資目標とする。同ファンドは通常、同指数の構成銘柄及びそれに基づく米国預託証券(ADR)で、その総資産の少なくとも90%を投資する。同指数は米国上場企業の約100社を含む。同ファンドの投資アドバイザーはInvesco PowerShares Capital Management LLC。     
本社所在地 --
代表者氏名
代表者役職名
電話番号 +1 800-983-0903
設立年月日 --
市場名 --
ipoyear ―年
従業員数 -
url http://www.invescopowershares.com/
nasdaq_url https://www.nasdaq.com/symbol/pdp
adr_tso
EBITDA EBITDA(百万ドル) 5.84348
終値(lastsale) 56.92
時価総額(marketcap) 1568146000
時価総額 時価総額(百万ドル) 1564.168
売上高 売上高(百万ドル) 15.28721
企業価値(EV) 企業価値(EV)(百万ドル) ー
当期純利益 当期純利益(百万ドル) 193.74210
決算概要 決算概要 BRIEF: For the fiscal year ended 30 April 2015 PowerShares DWA Technical Ldrs Pf (ETF) revenues increased 77% to $15.3M. Net income increased 26% to $193.7M. Revenues reflect Affiliated Dividend Income remaining flat at $0K. Net income was partially offset by Investments Securities decrease from $17.5M (income) to $51.4M (expense) Investment Securities- Unrealized decrease of 53% to $45M (income) Sub Licensing increase of 39% to $1.5M (expense).

 PDPのテクニカル分析


 PDPのニュース

   Pediatric Healthcare Market Forecast to 2027 by Studying Top Players as Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca plc., Pediapharm, Novartis AG, Eisai, Mylan N.V  2020/11/03 03:14:27 OpenPR
Pediatric healthcare is dealing with the treatment of child related diseases, their development and care. Children often suffer from respiratory, gastrointestinal and other chronic disease because of lower immunity. Increase in demand for chronic disease treatment, Diarrhea and injury related
   Pediatric Healthcare Market Forecast to 2027 by Studying Top Players as Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca plc., Pediapharm, Novartis AG, Eisai, Mylan N.V  2020/11/03 03:14:27 OpenPR
Pediatric healthcare is dealing with the treatment of child related diseases, their development and care. Children often suffer from respiratory, gastrointestinal and other chronic disease because of lower immunity. Increase in demand for chronic disease treatment, Diarrhea and injury related
   Pediatric Healthcare Market Forecast to 2027 by Studying Top Players as Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca plc., Pediapharm, Novartis AG, Eisai, Mylan N.V  2020/11/03 03:14:27 OpenPR
Pediatric healthcare is dealing with the treatment of child related diseases, their development and care. Children often suffer from respiratory, gastrointestinal and other chronic disease because of lower immunity. Increase in demand for chronic disease treatment, Diarrhea and injury related

 関連キーワード  (投資信託 米国株 PDP Invesco DWA Momentum ETF)

 twitter  (公式ツイッターやCEOツイッターなど)